Fructose impairs glucose-induced hepatic triglyceride synthesis

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Huang, Danshan ^a   Dhawan, Tania ^a   Young, Stephen ^a   Yong, William H ^a   Boros, Laszlo G ^b   Heaney, Anthony P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SIDMAP LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FRUCTOSE; GLUCOSE; HORMONE SENSITIVE LIPASE; SUCROSE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CELL STRAIN HEPG2; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; FATTY LIVER; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; LIPID HYDROLYSIS; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; LIVER; METABOLISM; NUDE MOUSE; ORGAN SIZE; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; FATTY LIVER; FRUCTOSE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEP G2 CELLS; HUMANS; LIVER; MALE; MICE; MICE, NUDE; ORGAN SIZE; TRIGLYCERIDES;

EID: 78751646546     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-20     Document Type: Article

References (46)

1. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. O Bayturan EM Tuzcu A Lavoie T Hu K Wolski P Schoenhagen S Kapadia SE Nissen SJ Nicholls, Arch. Intern. Med 2010 170 478 84 10.1001/archinternmed.2009.551 20212186
2. Fructose, insulin resistance, and metabolic dyslipidemia. H Basciano L Federico K Adeli, Nutr. Metab 2005 2 1 14 10.1186/1743-7075-2-5 (Pubitemid 40412656)
3. Metabolic effects of dietary fructose. J Hallfrisch, FASEB 1990 4 2652 2660
4. Intermediary metabolism of fructose. PA Mayes, Am. J. Clin. Nutr 1993 58 upp 5
5. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. LH Tetri M Basaranoglu EM Brunt LM Yerian BA Neuschwander Tetri, Am. J. Physiol. Gastrointest. Liver Physiol 2008 295 987 G995 10.1152/ajpgi.90272.2008 18772365
6. Fructose and metabolic syndrome: Pathophysiology and molecular mechanisms. AC Rutledge K Adeli, Nutrition Rev 2007 65 13 23 10.1301/nr.2007.jun.S13-S23
7. Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable"total cholesterol levels. GS Ginsburg C Safran RC Pasternak, Am. J. Cardiol 1991 1 187 92 10.1016/0002-9149(91)90742-4
8. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Heart Study. RD Abbot PWF Wilson WB Kannel WP Castelli, Arteriosclerosis 1988 8 207 11 3370018
9. HDL cholesterol and other N lipids in coronary hean disease: the cooperative lipoprotein pheno type study. WP Castelli JT Doyle T Gordon CG Hames MC Hjortland SB Hulley A Kagan WJ Zukel, Circulation 1977 55 767 72 191215
10. High-density and low density lipoproteins and prevalence of vascular disease in diabetesmellitus. JPD Reckless DJ Betteridge P Wu B Payne DJ Galton, Br. Med. J 1978 1 883 6 10.1136/bmj.1.6117.883 205308
11. High density lipoproteins, cholesterol transport and coronary heart disease. RJ Havel, Circulation 1979 60 1 3 221132
12. In vivo transport of cholesterol esters from high density lipoproteins to very low density lipoproteins in man. PJ Nestle M Readon T Billington, Biochim. Biophys. Acta 1979 573 403 7 221036
13. Risk factors for myocardial infarction in the Stockholm perspective study: a 14-year follow-up focusing on the role of plasma triglyceride and cholesterol. LA Carlson LE Bolliger PE Ahfeldt, Acta. N. Med. Scand 1979 706 351
14. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the II-year follow-up of the Paris Prospective Study. A Fontbonne E Eschwège F Cambien JL Richard P Ducimetière N Thibult JM Warnet JR Claude GE Rosselin, Diabetologia 1989 32 34 10.1007/BF00265546 2651187
15. The role of circulating glucose and triglyceride concentrations and their interaction with other "risk factors" as determinants of anerial disease in nine diabetic populations: samples from the WHO multinational study. KM West MM Ahuja PH Bennett A Czyzyk OM De Acosta JH Fuller B Grab V Grabauskas RJ Jarrett K Kosaka, Diabetes Care 1983 6 361 9 10.2337/diacare.6.4.361 6617413
16. Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease. CB Hollenbeck, Am. J. Clin. Nutr 1993 58 800S 809S 8213613
17. Role of insulin in endogenous hypenriglyceridemia. GM Reaven RL Lerner MP Stem JW Farquhar, J. Clin. Invest 1967 46 175 7 10.1172/JCI105666
18. Reappraisal of the role of insulin hypenriglyceridemia. JM Olefsky JW Farquhar GM Reaven, Am. J. Med 1974 57 551 10.1016/0002-9343(74)90006-0 4372881
19. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic men. TA Tobey MA Greenfield F Kraemer GM Reaven, Metabolism 1981 30 165 7I 10.1016/0026-0495(81)90167-0 7007804
20. Effect of fructose feeding on insulin secretion and insulin action in the rat. I Lavaroni S Sanders S Scoll GM Reaven, Metabolism 1980 29 970 3 10.1016/0026-0495(80)90041-4 6999292
21. Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats. LH Storlien EW Kraegan AD Jenkins OJ Chisholm, Am. J. Clin. Nutr 1988 47 420 7 3348154
22. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. AW Thorburn LH Storlien AD Jenkins, Am. J. Clin. Nutr 1989 49 1155 63 2658534
23. Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice. RC Davis LW Castellani M Hosseini O Ben-Zeev HZ Mao MM Weinstein DY Jung JY Jun JK Kim AJ Lusis M Péterfy, Diabetes 2010 59 1616 25 10.2337/db09-0878 20393148
24. Metabolic control analysis in drug discovery and disease. M Cascante LG Boros B Comin P Atauri JJ Centelles W-NP Lee, Nature Biotechnology 2002 20 246 249 10.1038/nbt0302-243 (Pubitemid 34205416)
25. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. JT Hwang IJ Park JI Shin YK Lee SK Lee HW Baik J Ha OJ Park, Biochem. Biophys. Res. Commun 2005 338 694 699 10.1016/j.bbrc.2005.09.195 16236247
26. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. C Postic J Girard, J. Clin. Invest 2008 118 829 10.1172/JCI34275 18317565
27. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. D Faeh K Minehira JM Schwarz R Periasamy S Park L Tappy, Diabetes 2005 54 1907 1913 10.2337/diabetes.54.7.1907 15983189
28. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. KA L D Faeh R Stettler M Ith R Kreis P Vermathen C Boesch E Ravussin L Tappy, Am. J. Clin. Nutr 2006 84 1374 1379 17158419
29. A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects. A Abdel-Sayed C Binnert KA L M Bortolotti P Schneiter L Tappy, Br. J. Nutr 2008 100 393 399 10.1017/S000711450789547X 18205992
30. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. KL Teff SS Elliott M Tschöp TJ Kieffer D Rader M Heiman RR Townsend NL Keim D D'Alessio PJ Havel, J. Clin. Endocrinol. Metab 2004 89 2963 72 10.1210/jc.2003-031855 15181085
31. Consumption of fructose sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. MM Swarbrick KL Stanhope SS Elliott JL Graham RM Krauss MP Christiansen SC Griffen NL Keim PJ Havel, Br. J. Nutr 2008 100 947 52 10.1017/S0007114508968252 18384705
32. Effects of consuming fructose- or glucose-sweetened beverages for 10 weeks on lipids, insulin sensitivity and adiposity. KL Stanhope JM Schwarz NL Keim SC Griffen AA Bremer JL Graham B Hatcher CL Cox A Dyachenko W Zhang JP McGahan A Seibert RM Krauss S Chiu EJ Schaefer M Ai S Otokozawa K Nakajima T Nakano C Beysen MK Hellerstein L Berglund PJ Havel, J. Clin. Invest 2009 119 1322 1334 10.1172/JCI37385 19381015
33. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. KA L M Ith R Kreis D Faeh M Bortolotti C Tran C Boesch L Tappy, Am. J. Clin. Nutr 2009 89 1760 1765 19403641
34. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. KL Teff J Grudziak RR Townsend TN Dunn RW Grant SH Adams NL Keim BP Cummings KL Stanhope PJ Havel, J. Clin. Endo. Metab 2009 94 1562 1569 10.1210/jc.2008-2192
35. Lipotoxicity: when tissues overeat. JE Schaffer, Curr. Opin. Lipidol 2003 14 281 287 10.1097/00041433-200306000-00008 12840659
36. Minireview: Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. RH Unger, Endocrinology 2003 144 5159 5165 10.1210/en.2003-0870 12960011
37. Lipid accumulation in non-adipose tissue and lipotoxicity. NA Van Herpen VB Schrauwen-Hinderling, Physiol. Behav 2008 94 231 241 10.1016/j.physbeh.2007. 11.049 18222498
38. Fat mobilizationin adipose tissue is promoted by adipose triglyceride lipase. R Zimmermann JG Strauss G Haemmerle G Schoiswohl R Birner-Gruenberger M Riederer A Lass G Neuberger F Eisenhaber A Hermetter R Zechner, Science 2004 306 1383 6 10.1126/science.1100747 15550674
39. Storing up trouble: does intramyocellular trigelyceride accumulation protect skeletal muscle form insulin resistance? MJ Watt, Proc. Aust. Physiol. Soc 2008 39 149 57
40. Glycolysis revisited. E Van Schaftingen, Diabetologia 1993 36 581 8 10.1007/BF00404065 8395434
41. Effects of fructose on hepatic glucose metabolism in humans. M Dirlewanger P Schneiter E Jéquier L Tappy, Am. J. Physiol. Endocrinol. Metab 2000 279 907 11 11001775
42. Spontaneous hyperglycemia and impaired glucose tolerance in athymic nude BALB/c mice. A Zeidler C Tosco D Kumar B Slavin J Parker, Diabetes 1982 31 821 5 10.2337/diabetes.31.9.821 6761217
43. Development of a diabetes-like syndrome in an athymic nude Balb/c mouse colony. A Zeidler D Kumar C Johnson J Parker, Exp. Cell Biol 1984 52 145 9 6365646
44. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies. K Buschard, Danish Med. Bull 1985 32 139 51
45. Histologic differentiation of human fetal pancreatic explants transplanted into nude mice. BE Tuch AB Ng A Jones JR Turtle, Diabetes 1984 33 1180 7 10.2337/diabetes.33.12.1180 6149970
46. Interaction of the level of dietary fat and type of carbohydrate in the regulation of hepatic liopgenesis in the mouse. GR Herzberg M Rogerson, Can. J. Physiol. Pharmacol 1982 60 912 9 6127153